Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) EBIT (2023 - 2025)

Historic EBIT for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $15.9 million.

  • Medical Group Holdings' EBIT rose 1479.36% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.4 million, marking a year-over-year decrease of 3373.72%. This contributed to the annual value of $70.3 million for FY2024, which is 50.43% down from last year.
  • Per Medical Group Holdings' latest filing, its EBIT stood at $15.9 million for Q3 2025, which was up 1479.36% from $14.6 million recorded in Q2 2025.
  • Over the past 5 years, Medical Group Holdings' EBIT peaked at $27.3 million during Q2 2024, and registered a low of -$473374.0 during Q2 2023.
  • For the 3-year period, Medical Group Holdings' EBIT averaged around $15.3 million, with its median value being $15.9 million (2025).
  • Over the last 5 years, Medical Group Holdings' EBIT had its largest YoY gain of 639709.72% in 2024, and its largest YoY loss of 8033.43% in 2024.
  • Over the past 3 years, Medical Group Holdings' EBIT (Quarter) stood at $24.0 million in 2023, then tumbled by 80.33% to $4.7 million in 2024, then surged by 236.63% to $15.9 million in 2025.
  • Its EBIT stands at $15.9 million for Q3 2025, versus $14.6 million for Q2 2025 and $24.2 million for Q1 2025.